Vol 41 # 3 September 2009 - Kma.org.kw

202
Population Health Genomics in Member Countries of the Cooperation Council for the Arab...
September 2009
factors, 2001: systematic analysis of population health
data. Lancet 2006; 367:1747-1757.
34. Al-Aqeel AI. Ethical guidelines in genetics and
genomics. An Islamic perspective. Saudi Med J 2005;
26:1862-1870.
35. Alkuraya FS, Kilani RA. Attitude of Saudi families
affected with hemoglobinopathies towards prenatal
screening and abortion and the influence of religious
ruling (Fatwa). Prenat Diagn 2001; 21:448-451.
36. Bhardwaj M, Macer DR. Policy and ethical issues
in applying medical biotechnology in developing
countries. Med Sci Monit 2003; 9:RA49-RA54.
37. Al-Gazali L, Eapen V. Genetics: global challenge,
regional focus. Advances in community and preventive
genetics. Community Genet 2005; 8:5-6.
38. Marrakech Declaration. Strengthening newborn
screening in the Middle East and North Africa; 2005
Nov 15 [conference proceedings on the Internet].
National Institute of Health, National Institute of Child
Health and Human Development; 2006. (Accessed
May 28, 2008 , at http://www.nichd.nih.gov/about/
meetings/2006/mena/agenda.cfm/)
39. Fatwa No. 4, 12th session of Islamic Jurisprudence
council of Islamic World League, Mekkah Al-
Mukaramah, 1990 Feb 10 - 17. Quoted in M. Albar :
“Al-Janin Al-Mushawah wa Al-Amradh Alwirathiyia,”
Dar AlQalam Damascus, Dar Almanara Jeddah, 1991.
p. 439 [available only in Arabic].
40. Albar MA. Counselling about genetic disease: an Islamic
perspective. East Mediterr Health J 1999; 5:1129-1133.
41. Albar MA. Ethical considerations in the prevention
and management of genetic disorders with special
emphasis on religious considerations. Saudi Med J
2002; 23:627-632
42. What is a “Fatwa” Islam. Religion and Spirituality.
About.com. (Accessed Nov 20, 2008, at http://islam.
about.com/od/law/g/fatwa.htm.)
43. Advisory Committee on Health Research. Genomics
and world health. Geneva, World Health Organization,
2002.
44. Rantanen E, Hietala M, Kristoffersson U, et al. What is ideal
genetic counselling A survey of current international
guidelines. Eur J Hum Genet 2008; 16:445-452.
45. Al Arrayed S. Campaign to control genetic blood
diseases in Bahrain. Community Genet 2005; 8:52-55.
46. El-Hazmi MA. Early recognition and intervention for
prevention of disability and its complications. East
Mediterr Health J 1997; 3:154-161.
47. Newborn Screening in Saudi Arabia. Country
Reports. Strengthening newborn screening in the
Middle East and North Africa: 2006. National
Institute of Health, National Institute of Child
Health and Human Development, 2006. (Accessed
May 28, 2008 at http://www.nichd.nih.gov/about/
meetings/2006/mena/agenda.cfm/)
48. Rashed MS, Rahbeeni Z, Ozand PT. Application of
electrospray tandem mass spectrometry to neonatal
screening. Semin Perinatol 1999; 23:183-193.
49. Report on newborn screening in Oman. Strengthening
newborn screening in the Middle East and North
Africa: 2006. National Institute of Health, National
Institute of Child Health and Human Development,
2006. (Accessed May 28, 2008, at http://www.nichd.
nih.gov/about/meetings/2006/mena/agenda.cfm/)
50. Bener A, Al Maadid MG, Al-Bast DA, Al-Marri S.
Maternal knowledge, attitude and practice on folic acid
intake among Arabian Qatari women. Reprod Toxicol
2006; 21:21-25.
51. Miller CJ, Dunn EV, Berg B, Abdouni SF. A hematological
survey of preschool children of the United Arab
Emirates. Saudi Med J 2003; 24:609-613.
52. United Nations Department of Economic and Social
Affairs Population Division: Abortion policies: a global
review. New York: United Nations, 2001. (Accessed
May 28, 2008, at http://www.un.org/esa/population/
publications/abortion/).
53. Raeburn S. Genetics and global health care. Community
Genet 2005; 8:12-16.
54. Nadkarni KV, Al-Arrayed SS, Bapat JP. Incidence of genetic
disorders of hemoglobin in the hospital population of
Bahrain. Bahrain Med Bull 1991; 131:19-24.
55. El-Kalla S, Baysal E. Alpha-thalassemia in the United
Arab Emirates. Acta Haematol 1998; 100:49-53.
56. Diejomaoh FM, Haider MZ, Dalal H, Abdulaziz
A, D’Souza TM, Adekile AD. Influence of alphathalassemia
trait on the prevalence and severity of
anemia in pregnancy among women in Kuwait. Acta
Haematol 2000; 104:92-94.
57. Nagel RL, Daar S, Romero JR, et al. HbS-Oman
heterozygote: a new dominant sickle syndrome. Blood
1998; 92:4375-4382.
58. Fawzi ZO, Al Hilali A, Fakhroo N, Al Bin Ali A, Al
Mansour S. Distribution of hemoglobinopathies
and thalassemias in Qatari nationals seen at Hamad
Hospital in Qatar. Qatar Med J 2003; 12:20-24.
59. Nasserullah Z, Al Jame A, Abu Srair H, et al. Neonatal
screening for sickle cell disease, glucose-6-phosphate
dehydrogenase deficiency and α-thalassemia in Qatif
and Al Hasa. Ann Saudi Med 1998; 18:289-292.
60. Dash S. Hemoglobinopathies, G6PD deficiency, and
hereditary elliptocytosis in Bahrain. Hum Biol 2004;
76:779-783.
61. Marouf R, D’Souza TM, Adekile AD. Hemoglobin
electrophoresis and hemoglobinopathies in Kuwait.
Med Princ Pract 2002; 11:38-41.
62. Al-Riyami A, Ebrahim GJ. Genetic blood disorders
survey in the Sultanate of Oman. J Trop Pediatr 2003;
49:S1-S20.
63. Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry
AJ. Premarital screening for thalassemia and sickle cell
disease in Saudi Arabia. Genet Med 2007; 9:372-377.
64. Sawardekar KP. Profile of major congenital
malformations at Nizwa Hospital, Oman: 10-year
review. J Paediatr Child Health 2005; 41:323-330.
65. Al-Kandari JM, Alshuaib WB. Newborn hearing
screening in Kuwait. Electromyogr Clin Neurophysiol
2007; 47:305-313.
66. Khandekar R, Khabori M, Jaffer Mohammed A, Gupta
R. Neonatal screening for hearing impairment – The
Oman experience. Int J Pediatr Otorhinolaryngol 2006;
70:663-670.
67. Bener A, Eihakeem AA, Abdulhadi K. Is there any
association between consanguinity and hearing loss.
Int J Pediatr Otorhinolaryngol 2005; 69:327-333.
68. Habib HS, Abdelgaffar H. Neonatal hearing screening
with transient evoked otoacoustic emissions in Western